Abiopharma

Tender offer - specification

Transaction with a controlling shareholder

Holdings of interested parties/officers as of 31.3.26

General Announcement: Press Release - Serial Achieva secures contract for AI infrastructure solutions

Events and transactions

Oruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-A Trial on April 27, 2026

Prospectus, shelf prospectus, shelf offering report

Issuance results - periodic report amendment

Register of shareholders, changes and share capital status – exercise of non-tradable warrants into the company’s shares and conversion of BONDS (series 1) into the company’s shares according to their terms

An investor call will be held ahead of the issuance of BONDS 2 on 30.4.26

Holdings of interested parties/officers as of 31.3.26

General Announcement: Net Tangible Assets (NTA) Per Unit

General Announcement: Net Tangible Assets (NTA) Per Unit

Adagio Medical Announces Positive Pivotal Results for vCLAS® Ventricular Ablation System

General Announcement: Net Tangible Assets (NTA) Per Unit